⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVBP News
ArriVent BioPharma, Inc. Common Stock
Defining Moments in the Race for Biotech Breakthroughs
globenewswire.com
AVBP
NTHI
XNCR
AZTR
Form 8-K
sec.gov
AVBP
ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
globenewswire.com
AVBP
ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026
globenewswire.com
AVBP
ARRIVENT BIOPHARMA AVBP INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 47.3% Share Drop
businesswire.com
AVBP
Form 8-K
sec.gov
AVBP
ArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung Cancer
globenewswire.com
AVBP
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ArriVent BioPharma, Inc. (AVBP) And Encourages Investors to Reach Out
accessnewswire.com
AVBP
ARRIVENT BIOPHARMA INVESTIGATION: AVBP Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
globenewswire.com
AVBP
ArriVent BioPharma (AVBP) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com
AVBP